Zeskind Benjamin J.
SEC insider (Form 3/4/5 filer). CIK 0001870062. PRESIDENT AND CEO at Immuneering Corp (IMRX). 6 reported Form 4/5 transactions since Sep 2024; latest on Jun 23, 2026. Located in CAMBRIDGE, MA.
Companies Zeskind Benjamin J. has filed insider reports for
- Immuneering Corp (IMRX): Director, Officer, PRESIDENT AND CEO
Zeskind Benjamin J.
CIK: 0001870062
Transaction Breakdown
Open Market Buys (P)4 (66.7%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (33.3%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
IMRX
Immuneering Corp
DirectorOfficer
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Jun 23, 2026IMRX
Immuneering Corp
PurchaseDirect2.4K shares at avg. $4.56$11K - Feb 3, 2026IMRX
Immuneering Corp
AwardDirectStock Option
688K shares- - Jul 2, 2025IMRX
Immuneering Corp
PurchaseDirect7K shares at avg. $3.53$25K - Jul 1, 2025IMRX
Immuneering Corp
PurchaseDirect3K shares at avg. $3.38$10K - Jun 18, 2025IMRX
Immuneering Corp
PurchaseDirect21K shares at avg. $2.39$50K - Feb 5, 2025IMRX
Immuneering Corp
AwardDirectStock Option
480K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 23, 2026 | IMRX Immuneering Corp | Purchase | 2,400 | $4.56 | $10,948 | Direct |
| Feb 3, 2026 | IMRX Immuneering Corp | Award Stock Option | 688,000 | - | - | Direct |
| Jul 2, 2025 | IMRX Immuneering Corp | Purchase | 7,015 | $3.53 | $24,792 | Direct |
| Jul 1, 2025 | IMRX Immuneering Corp | Purchase | 2,985 | $3.38 | $10,087 | Direct |
| Jun 18, 2025 | IMRX Immuneering Corp | Purchase | 21,000 | $2.39 | $50,144 | Direct |
| Feb 5, 2025 | IMRX Immuneering Corp | Award Stock Option | 480,000 | - | - | Direct |
1-6 of 6 transactions